K. Battmer, R. Jacobs, J. Casper, H. Diedrich, J. Schubert, J. Kühl, and H. Poliwoda. 1997. Transplantation of Allogeneic Peripheral Blood Progenitor Cells Alone or in Addition to Bone Marrow. In Acute [...] J. Kadar, K. Battmer, R. Jacobs, H. Diedrich, J. Schubert, J. Kühl, and H. Poliwoda. 1995. Transplantation of allogeneic peripheral blood progenitor cells alone or in addition to bone marrow. In Acute
be known until May 2025 which Clusters of Excellence will be funded. The HTTG Clinic with its transplantation medicine and new organ perfusion strategies, but above all the LEBAO with its pluripotent stem
iomyocytes (hiPSC-CMs) to investigate the cardiac electrophysiology in vitro and after cell transplantation in vivo. The genetically encoded calcium indicators (GECIs) GCaMP6f or RCaMP1h were successfully
specificity with clinical significance, such as Treg-mediated GVHD prevention in allo-HSCT transplantation. Former Team Members Leonie Kuhlmann Jessica Schneider Maleen Beck Abdi Demera Melanie Drenker
annover.de Dr. rer. nat Jörg Mengwasser Dr. rer. nat Jörg Mengwasser Head of Research area "Transplantation and Regeneration" ☎ 0511-532 4201, mobil 17-2678 E-Mail: Mengwasser.Joerg(at)mh-hannover.de Mr
Outpatient clinics Allergies Cystic Fibrosis Diseases of the immune system HIV Lung diseases Lung transplantation Premature infant aftercare / monitor consultation Private outpatient clinic Rheumatic diseases
2015. Striatal Transplantation of Human Dopaminergic Neurons Differentiated From Induced Pluripotent Stem Cells Derived From Umbilical Cord Blood Using Lentiviral Reprogramming. Cell Transplant 24, no. 10:2099 [...] of human lymphocytes in a porcine microenvironment: implication for xenogeneic organ transplantation. Transplant Proc 32, no. 5:1043. Laaf, G., Schuster, S., Martin, U., Steinhoff, G., Haverich, A., and [...] columns and by extracorporeal kidney perfusion in the setting of discordant xenogeneic lung transplantation. Transplant Proc 32, no. 5:879. Simon, A. R., Schroder, C., Martin, U., Chikobava, M., Templin, C.
surrounding the topic of cell therapies, such as "Can these therapies offer an alternative to organ transplantation?", "How is research using patient stem cells regulated in terms of ethics and the law?", "Why
already manufactured for your patient as well as the delivery of selected preparations for transplantation or infusion. Make sure to fill in the form completely with the data relating to the planned
ic T cells in optimizing T-cell immunity in transplant recipients Supervisor: Prof. Dr. Britta Eiz-Vesper, Institute of Transfusion Medicine and Transplant Engineering, MHH Academic Background: Biotechnology